Previous Nav
Net Change on 01-02-2023
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Max Healthcare Institute Ltd.
Cipla Ltd.
Aether Industries Ltd.
Global Health Ltd.
Apollo Hospitals Enterprise Ltd.
Rainbow Children's Medicare Ltd.
Abbott India Ltd.
Krishna Institute Of Medical Sciences Ltd.
Fortis Healthcare Ltd.
Medplus Health Services Ltd.
JB Chemicals & Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd.
Narayana Hrudayalaya Ltd.
Alkem Laboratories Ltd.
Lupin Ltd.
Divi's Laboratories Ltd.
Gland Pharma Ltd.
TREPS
Ami Organics Ltd.
Gufic Biosciences Ltd.
Shreno Ltd.
Net Receivable / Payable
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Chemicals
Miscellaneous
Cash
CRISIL A
Equity
SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 14-Jul-1999 and currently has an AUM of ₹1,660.46 crore. SBI Healthcare Opportunities Fund is benchmarked against S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.
The NAV of SBI Healthcare Opportunities Fund ended down ₹-2.12(-0.97%)yesterday to ₹217.909.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .
191, Maker Tower 'E' Cuffe Parade Mumbai - 400 005